Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg is a combination oral antidiabetic medication designed to improve blood sugar control in adults with type 2 diabetes mellitus. Sitagliptin is a DPP-4 inhibitor that increases the levels of incretin hormones, enhancing insulin release and decreasing glucagon production in response to meals. Metformin hydrochloride is a biguanide that decreases hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake. Together, this combination effectively helps manage hyperglycemia, especially in patients who do not achieve adequate control with diet and exercise alone. This medication is typically prescribed alongside lifestyle interventions such as diet modification, regular exercise, and weight management to optimize glycemic control. It offers the convenience of a single tablet therapy, enhancing adherence to treatment.
